Cargando…
Clinical trials using molecular stratification of pediatric brain tumors
Brain cancer is now the leading cause of cancer death in children and adolescents, surpassing leukemia. The heterogeneity and invasiveness of pediatric brain tumors have historically made them difficult to treat. Although surgical intervention and standard of care therapies such as radiation and che...
Autores principales: | Hanz, Samuel Z., Adeuyan, Oluwaseyi, Lieberman, Grace, Hennika, Tammy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7237976/ https://www.ncbi.nlm.nih.gov/pubmed/32477915 http://dx.doi.org/10.21037/tp.2020.03.04 |
Ejemplares similares
-
PET, image-guided HDAC inhibition of pediatric diffuse midline glioma improves survival in murine models
por: Tosi, Umberto, et al.
Publicado: (2020) -
Molecular Imaging in Pediatric Brain Tumors
por: Chiaravalloti, Agostino, et al.
Publicado: (2019) -
An update on methods for detection of prognostic and predictive biomarkers in melanoma
por: Adeuyan, Oluwaseyi, et al.
Publicado: (2023) -
Clinical and molecular stratification of disease risk in medulloblastoma
por: Gilbertson, R, et al.
Publicado: (2001) -
Improved stratification of ALS clinical trials using predicted survival
por: Berry, James D., et al.
Publicado: (2018)